Reaction
Duodenal Stenosis reporting signals
As of the last recalculation, Duodenal Stenosis appears in 475 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is ERLOTINIB (PRR 32.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Erlotinib | 7 | 32.1 | 32.1 |
| Erlotinib Hydrochloride | 9 | 32.1 | 32.1 |
| Gemcitabine | 23 | 26.8 | 26.8 |
| Gemcitabine Hydrochloride | 29 | 25.4 | 25.5 |
| Irinotecan Hydrochloride | 6 | 20.7 | 20.7 |
| Durvalumab | 7 | 15.3 | 15.3 |
| Encorafenib | 3 | 13.4 | 13.4 |